company

MEDILENS NORGE AS

1782 HALDEN

Return on Equity
38,48 %
Current Ratio
1,44
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue5 573 000
Net Income304 000
Total Assets2 589 000
Total Equity790 000
Income (NOK)2022
Revenue5 573 000
Expenditure5 171 000
Operating Profit402 000
Financial Income0
Financial Costs10 000
Financial Balance−10 000
Earnings Before Tax393 000
Tax89 000
Net Income304 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets2 589 000
Total Assets2 589 000
Total Retained Equity760 000
Total Equity790 000
Total Long-Term Debt0
Total Current Debt1 799 000
Total Equity and Debt2 589 000
Cash flow (NOK)2022
Sales Income5 226 000
Other Income347 000
Revenue5 573 000
Cost of Goods Sold0
Salary Costs2 427 000
Depreciation0
Impairment0
Expenditure5 171 000
Operating Profit402 000
Financial Income0
Financial Costs10 000
Financial Balance−10 000
Dividends0
Net Income304 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank379 000
Total Current Assets2 589 000
Total Assets2 589 000
Total Equity790 000
Short-Term Group Debt899 000
Total Long-Term Debt0
Creditors21 000
Unpaid Taxes27 000
Dividends0
Other Current Debt764 000
Total Current Debt1 799 000
Total Equity and Debt2 589 000
Financial indicators2022
Return on Equity38,48 %
Debt-to-Equity Ratio0
Operating Profit Margin7,21 %
Current Ratio1,44
Quick Ratio1,44
Equity Ratio0,31
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English